What is the appropriate work‑up and management for a patient with intermittent (waxing‑and‑waning) flank pain, a sensation of bladder pressure, and imaging evidence of hydronephrosis suggesting a partially obstructing ureteral stone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Intermittent Flank Pain with Hydronephrosis and Ureteral Stone

Obtain a non-contrast CT scan of the abdomen and pelvis immediately to determine stone size, exact location, degree of obstruction, and presence of complications—this imaging is essential before any treatment decision and achieves 97–100% sensitivity for detecting stones while identifying alternative diagnoses in one-third of cases. 1, 2

Immediate Clinical Assessment

Check for red-flag features requiring emergency intervention:

  • Fever, chills, or signs of systemic infection indicate possible obstructive pyelonephritis or urosepsis and mandate immediate hospital admission, intravenous antibiotics, and urgent urologic decompression (percutaneous nephrostomy or ureteral stent) within hours 2, 3
  • Hemodynamic instability or shock requires emergent evaluation 2
  • Inability to urinate or significantly decreased urine output necessitates urgent assessment 2

Provide rapid analgesia within 30 minutes:

  • Intramuscular diclofenac 75 mg is the preferred first-line analgesic, with pain reassessment at 1 hour 2
  • Failure to achieve adequate pain control after 1 hour mandates immediate hospital admission 2

Essential Laboratory Work-Up Before Imaging

Obtain the following tests before proceeding with imaging:

  • Urinalysis with microscopy to detect hematuria, pyuria, bacteriuria, and crystals—though note that >20% of confirmed stone cases have negative urinalysis, so absence of hematuria does not exclude stone disease 2
  • Urine culture if infection is suspected (fever, dysuria, pyuria) 2
  • Serum creatinine to assess baseline renal function 2
  • Complete blood count to identify leukocytosis 2
  • Beta-hCG in all women of reproductive age before imaging to exclude ectopic pregnancy 2

Imaging Strategy

Non-contrast CT abdomen and pelvis is the mandatory first-line study for this clinical scenario, providing:

  • 98–100% sensitivity and 96–100% specificity for detecting urinary stones of any size, location, or composition 2
  • Critical management information including stone size, anatomical location, degree of hydronephrosis, and presence of complications 2
  • Detection of alternative diagnoses in approximately one-third of patients with acute flank pain 1, 2

Low-dose CT protocols should be used when available, maintaining 92–99% sensitivity while markedly reducing radiation exposure 2

If Initial Non-Contrast CT Shows No Stone

When non-contrast CT fails to demonstrate a stone but clinical suspicion remains high:

  • Proceed to CT urography (CTU) with intravenous contrast or contrast-enhanced CT abdomen/pelvis to assess for radiolucent calculi, other urinary-tract pathology, and non-urologic causes 1
  • CTU with delayed excretory phase is preferred because it confirms ureteral location of calculi and distinguishes stones from mimics such as phleboliths 1
  • Contrast-enhanced CT retains 95% sensitivity for stones ≥3 mm and 98% sensitivity for clinically significant stones ≥6 mm 2
  • Contrast studies identify alternative diagnoses in 5–18% of cases, though these findings alter management in only 2–3% of patients 1, 2

Alternative Imaging Considerations

Ultrasound has significant limitations in this scenario:

  • Only 24–57% sensitivity for direct stone visualization, particularly poor for stones <5 mm 1, 2, 3
  • Up to 100% sensitivity for detecting hydronephrosis, ureterectasis, and perinephric fluid 1, 2
  • Absence of hydronephrosis on ultrasound makes stones >5 mm unlikely 1, 2
  • Secondary signs of obstruction may not appear within the first 2 hours of symptom onset, reducing early sensitivity 2

Management Based on Stone Characteristics

Stones <5 mm

Conservative management with medical expulsive therapy is appropriate:

  • These stones typically pass spontaneously 1, 2
  • Alpha-blockers (tamsulosin) increase stone passage rates by 29% compared to placebo, with distal ureteral stones <10 mm achieving 77.3% stone-free rates versus 54.4% with placebo 4
  • Maximum observation period is 6 weeks from initial presentation to prevent irreversible kidney injury 4

Stones 5–10 mm

Initial trial of medical expulsive therapy is reasonable:

  • Alpha-blocker therapy for up to 6 weeks 4
  • Proceed to ureteroscopy if stone does not pass within 6 weeks or if symptoms worsen 4

Stones >10 mm or Complete Obstruction

Active intervention is required:

  • Ureteroscopy is first-line therapy, achieving stone-free rates of 95% for stones <10 mm and 78% for stones >10 mm 4
  • Ureteroscopy provides higher single-procedure stone-free rates than shock-wave lithotripsy (81–93% vs. 73–87% for proximal stones) 4
  • Flexible ureteroscopy combined with holmium:YAG laser lithotripsy is the optimal technique 4

Special Consideration for Proximal Ureteral Stones

Stones ≥9 mm in the proximal ureter warrant ureteroscopy because:

  • Spontaneous passage rates are very low 4
  • Ureteroscopy achieves 81–93% stone-free rates for proximal ureteral stones 4
  • The 2007 American Urological Association guidelines state that ureteroscopy is appropriate for stones of any size in the proximal ureter 4

Degree of Hydronephrosis and Treatment Implications

The degree of hydronephrosis does not significantly affect overall treatment success but does influence treatment course:

  • Stones in obstructed systems require more repeat treatments (2.2 vs. 1.6 sessions, p<0.001) 5
  • Prolonged stone clearance time (18.7 vs. 15.4 days, p<0.001) in patients with hydronephrosis 5
  • Stones >6 mm located in the proximal two-thirds of the ureter with five or more secondary signs of obstruction are more likely to require endoscopic removal 6

Follow-Up Imaging After Treatment

Renal ultrasound at 1 month after ureteroscopy (or 1 month after stent removal if stent placed):

  • Detects hydronephrosis in approximately 9.3% of patients post-ureteroscopy 7
  • Silent (asymptomatic) hydronephrosis occurs in 4.8% of patients and may warrant further surgery 7
  • The negative predictive value of ipsilateral flank pain for hydronephrosis is 94%, but positive predictive value is only 35% 7

Critical Pitfalls to Avoid

Do not assume absence of hematuria excludes stone disease—more than 20% of confirmed stone cases have negative urinalysis 2

Do not delay imaging in women of reproductive age—gynecologic emergencies (ectopic pregnancy, ovarian torsion) must be ruled out promptly 2

Never ignore fever in a stone patient—infected obstructed kidney is a urological emergency requiring immediate decompression 3, 4

Avoid prolonged conservative management beyond 6 weeks—this risks irreversible kidney damage 4

Do not miss hemorrhagic cystitis as a cause of acute unilateral hydronephrosis—blood can acutely obstruct the distal ureter and cause transient obstructive uropathy even when recent CT showed no stone 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach for Flank Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

CT Scan Prior to Admission for UPJ Stone with Obstruction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Ureteric Stones in Young Adults with Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Acute unilateral hydronephrosis in the setting of hemorrhagic cystitis.

The American journal of emergency medicine, 2022

Related Questions

Is a right lower ureteral elongated stone measuring 14 mm × 6 mm with a density of 1000 Hounsfield units, rough surface, located 30 mm proximal to the vesicoureteric junction and causing moderate‑to‑severe right hydronephrosis an indication for complex ureteroscopy?
Is a right lower ureteric stone measuring 14 × 6 mm with a density of 1000 Hounsfield units, rough surface, located 30 mm from the vesico‑ureteric junction and causing moderate to severe right hydronephrosis indicated for flexible ureteroscopy with laser lithotripsy and double‑J stent placement?
What is the management for a 4 mm stone in the distal ureter with mild hydronephrosis?
How to manage a patient with a 0.3 cm obstructing calculus in the ureter and associated hydroureter?
Can a clinically stable adult with a 2 mm distal ureteral stone, moderate hydronephrosis, no infection or renal impairment, and no major comorbidities (uncontrolled diabetes, coagulopathy, severe cardiac disease) be safely discharged?
How should hormonally driven pseudoangiomatous stromal hyperplasia (PASH) be managed?
Can meningioma present initially with psychiatric symptoms in otherwise healthy adults?
Is a 5‑day course of prednisone (Wysolone) 20 mg daily appropriate for a 70‑year‑old woman with seropositive rheumatoid arthritis, total thyroidectomy, chronic obstructive pulmonary disease, and age‑related bone loss, and what monitoring and adjunctive measures are recommended?
Is a 5‑day course of prednisone 20 mg daily an appropriate bridge before initiating a disease‑modifying antirheumatic drug in an adult with rheumatoid arthritis, and what baseline tests and precautions are required?
Is it normal to feel significant pain relief after just two 20 mg doses of prednisone, and how should I continue and taper the steroid while waiting for methotrexate to take effect?
What is the trimethoprim‑sulfamethoxazole (Bactrim) dose for uncomplicated urinary‑tract infection in a non‑pregnant adult, and how should it be adjusted for reduced renal function and in children?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.